Advances in the development of molecularly targeted agents in non-small-cell lung cancer

SO Dolly, DC Collins, R Sundar, S Popat, TA Yap - Drugs, 2017 - Springer
Non-small-cell lung cancer (NSCLC) remains a significant global health challenge and the
leading cause of cancer-related mortality. The traditional 'one-size-fits-all'treatment …
被引用次数：61 相关文章

Advances in the Development of Molecularly Targeted Agents in Non-Small-Cell Lung Cancer.

S Dolly, D Collins, R Sundar, S Popat, T Yap - Drugs, 2017 - search.ebscohost.com
Non-small-cell lung cancer (NSCLC) remains a significant global health challenge and the
leading cause of cancer-related mortality. The traditional'one-size-fits-all'treatment approach …

Advances in the Development of Molecularly Targeted Agents in Non-Small-Cell Lung Cancer

SO Dolly, DC Collins, R Sundar, S Popat… - Drugs, 2017 - mdanderson.elsevierpure.com
Non-small-cell lung cancer (NSCLC) remains a significant global health challenge and the
leading cause of cancer-related mortality. The traditional 'one-size-fits-all'treatment …

Advances in the Development of Molecularly Targeted Agents in Non-Small-Cell Lung Cancer

SO Dolly, DC Collins, R Sundar, S Popat, TA Yap - Drugs, 2017 - pubmed.ncbi.nlm.nih.gov
Non-small-cell lung cancer (NSCLC) remains a significant global health challenge and the
leading cause of cancer-related mortality. The traditional'one-size-fits-all'treatment approach …

Advances in the Development of Molecularly Targeted Agents in Non-Small-Cell Lung Cancer.

SO Dolly, DC Collins, R Sundar, S Popat, TA Yap - Drugs, 2017 - europepmc.org
Non-small-cell lung cancer (NSCLC) remains a significant global health challenge and the
leading cause of cancer-related mortality. The traditional'one-size-fits-all'treatment approach …

Advances in the Development of Molecularly Targeted Agents in Non-Small-Cell Lung Cancer

SO Dolly, DC Collins, R Sundar, S Popat, TA Yap - Drugs, 2017 - infona.pl
Non-small-cell lung cancer (NSCLC) remains a significant global health challenge and the
leading cause of cancer-related mortality. The traditional 'one-size-fits-all'treatment …

Advances in the Development of Molecularly Targeted Agents in Non-Small-Cell Lung Cancer

SO Dolly, DC Collins, R Sundar, S Popat, TA Yap - Drugs, 2017 - search.proquest.com
Non-small-cell lung cancer (NSCLC) remains a significant global health challenge and the
leading cause of cancer-related mortality. The traditional'one-size-fits-all'treatment approach …